Activity-Based Therapeutic Algorithm for Folliculitis Decalvans: A Practical Tool for Effective Management

    Anna Bolzon, Antonella Tosti
    Image of study
    TLDR A new treatment plan helps manage folliculitis decalvans effectively.
    The study presents a therapeutic algorithm for managing folliculitis decalvans (FD), a common form of scarring alopecia. It emphasizes the importance of accurate diagnosis and management to prevent irreversible scarring and systemic complications. The algorithm is based on disease activity, assessed using the Investigator's Global Assessment score and the Trichoscopy Activity Scale. Management is divided into acute and mild inflammatory phases, with oral antibiotics and corticosteroids recommended for the acute phase, and oral isotretinoin for mild activity. The study highlights the lack of clinical trials for FD treatments and the off-label use of medications, while also cautioning against the use of antibiotics essential for systemic infections due to resistance risks. The algorithm includes additional systemic and topical therapies, offering a structured guideline for dermatologists and paving the way for future research on FD treatment strategies.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 92 results

      community DHT Harms Scalp Microbiome: DHT Itch is REAL

      in Research/Science  412 upvotes 9 months ago
      Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 1 year ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community Hair Loss “Cure” for Inflammation: Topical Roflumilast

      in Research/Science  32 upvotes 2 weeks ago
      Topical roflumilast is effective for reducing inflammation in various scalp conditions like seborrheic dermatitis, psoriasis, and eczema, but not proven to stop scarring alopecia. Alternatives like apremilast and Vtama are also discussed for their anti-inflammatory benefits.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    5 / 1000+ results
      Primary Cicatricial Alopecias

      research Primary Cicatricial Alopecias

      1 citations , April 2010 in “Expert Review of Dermatology”
      The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.
      Cicatricial Alopecia: Overview and Treatment Recommendations

      research Cicatricial Alopecia: Overview and Treatment Recommendations

      23 citations , April 2018 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.